Abstract G protein-coupled receptors (GPCRs) function as receptors for various neurotransmitters, hormones, cytokines, and metabolites. GPCR ligands impart differing degrees of signaling in the G protein and arrestin pathways, in phenomena called biased signaling, and each ligand for a given GPCR has a characteristic level of ability to activate or deactivate its target, which is referred to as its efficacy. The ligand efficacies and biased signaling of GPCRs remarkably affect the therapeutic properties of the ligands. However, these features of GPCRs can only be partially understood from the crystallography data, although numerous GPCR structures have been solved. NMR analyses have revealed that GPCRs have multiple interconverting substates, exchanging on various timescales, and that the exchange rates are related to the ligand efficacies and biased signaling. In addition, NMR analyses of GPCRs in the lipid bilayer environment of rHDLs revealed that the exchange rates are modulated by the lipid bilayer environment, highlighting the importance of the function-related dynamics in the lipid bilayer. In this review, we will describe several solution NMR studies that have clarified the conformational dynamics related to the ligand efficacy and biased signaling of GPCRs.
G protein-coupled receptors (GPCRs) are one of the largest membrane protein families in eukaryotes and share a structural topology that is characterized by seven transmembrane helices (TMI to TMVII). GPCRs function as receptors of various chemical messengers, including neurotransmitters, hormones, cytokines (chemokines), and metabolites. Over 30% of modern drugs target GPCRs, and currently more than 300 agents are in clinical trials (Hauser et al. 2017) .
Growing numbers of GPCR structures have been solved by X-ray crystallography, and the number of cryo-electron microscopy structures of GPCRs in complexes with their binding partners is rapidly increasing. At present, the structures of more than 60 different GPCRs and over 300 of their complexes with different ligands are available, as documented by GPCRdb-a database dedicated to the GPCR family (Pándy-Szekeres et al. 2018) . These structures have strongly promoted our understanding of how GPCRs transmit their signals into the cells. However, crystallography data alone cannot fully explain the important features of GPCR signaling as observed. In addition, the observed conformation may not be the major state in the lipid bilayer environment at the physiological temperature. Recent results have suggested that GPCRs are structurally dynamic and exchange between multiple conformations (Gregorio et al. 2017; Kahsai et al. 2011; Manglik et al. 2015; West et al. 2011) .
In relation to this point, NMR methods provide information about the dynamics of proteins over a wide range of frequencies, in aqueous solutions at near-physiological temperatures (Ikeya et al. 2018; Mittermaier and Kay 2009; Osawa et al. 2012) . Advances in the NMR techniques describing conformational dynamics have revealed that the global and local conformational fluctuations of This article is part of a Special Issue dedicated to the B2018 Joint Conference of the Asian Biophysics Association and Australian Society for Biophysics^edited by Kuniaki Nagayama, Raymond Norton, Kyeong Kyu Kim, Hiroyuki Noji, Till Böcking, and Andrew Battle.
protein structures are closely related to their functions, such as enzymatic activities (Bhabha et al. 2011; Kerns et al. 2015 ) and molecular recognition (Lange et al. 2008) , especially for membrane proteins (Brüschweiler et al. 2015; Minato et al. 2016; Morrison et al. 2011; Nishida et al. 2014) .
Although NMR studies of GPCRs are challenging, recent methodological advances have enabled us to observe the NMR signals of various GPCRs, and these NMR studies have revealed that GPCRs exist in function-related equilibria between locally different conformations that are simultaneously populated . In this review, we will describe several solution NMR studies that have identified the function-related dynamics of two GPCRs, β 2 adrenergic receptor, and μ-opioid receptor.
Ligand efficacy-related conformational dynamics of β 2 adrenergic receptor Activated GPCRs induce signal transduction mediated by G proteins, arrestins, and various other effectors (Fig. 1a) . GPCRs exhibit basal activities in the absence of the ligands, and each chemical ligand for a GPCR has different levels of ability to activate or inhibit their target, which is commonly referred to as its efficacy. The ligands are classified according to their efficacies, with such descriptions as full agonists, partial agonists, neutral antagonists, and inverse agonists (Fig. 1b) , and these differences in the efficacies significantly affect the therapeutic properties of the GPCR ligands. For instance, in the case of drugs that target the β 2 -adrenergic receptor (β 2 AR), a full agonist offers a clinical advantage over a partial agonist in the treatment of acute severe asthma, although the use of full agonists is associated with more adverse effects (Hanania et al. 2010) .
The crystal structures of β 2 AR have been solved in the inverse agonist-bound form and the ternary complex form bound to the full agonist and a G protein (Cherezov et al. 2007; Rasmussen et al. 2011 ). In the ternary complex form, the full agonist induces the repositioning of P211 5.50 , I121 3.40 , and F282 6.44 , which are in the central part of β 2 AR, as compared with the inverse agonist-bound form where they are located (Fig. 1c) . (Superscripts indicate BallesterosWeinstein numbering (Ballesteros and Weinstein 1995) . The first and second numbers denote the transmembrane helix number and the residue number relative to the most conserved residue in the helix, which is assigned 50.) These residues are referred to as the P/I/F motif and are widely conserved among the GPCRs. In the ternary complex form, the repositioning of the P/I/F motif accompanies the movement of the intracellular side of TMIII, V, VI, and VII, to form a cavity on the cytoplasmic surface. The C-terminal helix of the engineered G protein was inserted into the cavity. Although these structures indicated the activation mechanism of β 2 AR, the mechanism underlying the differences in the efficacy was not clear.
NMR was utilized to examine correlations between the ligand efficacy and the β 2 AR conformations (Kofuku et al. 2012) . Methionine residues are frequently observed in TMIII, TMV, and TMVI of GPCRs, and these regions exhibit large conformational changes upon activation. In the case of β 2 AR, M82
2.53 exists in the central transmembrane region, and the M82 2.53 side-chain conformation is sensitive to the activation of the P/I/F motif (Fig. 1c) . Therefore, the methionine methyl groups were utilized to investigate the conformation of the TM region of β 2 AR, in the presence of compounds with different efficacies for β 2 AR. In the inverse agonist-bound state, M82 exhibited two signals, referred to as M82 D and M82 U , respectively (Fig. 1d) (Fig. 1d) . H chemical shifts of the methionine methyl signals are reportedly affected by the side-chain conformations and the local environments, including the ring current effects from the neighboring aromatic rings (Butterfoss et al. 2010; Perkins and Wüthrich 1979) . The side-chain conformation and the local environment that correspond to the chemical shifts of M82 U and M82 D from NMR studies are in good agreement with the inactive P/I/F motif conformation in the crystal structures of β 2 AR in its complexes with inverse agonists, and those of M82
A are in good agreement with the active Fig. 1 , and C327 7.54 , and the bound ligands are depicted by sticks. The C-terminal region of the α subunit of the G-protein is shown as a purple ribbon. D signals, do not. In the full agonist formoterol-bound state, β 2 AR primarily adopts the PIFon conformation, exhibiting almost the full efficacy of β 2 AR. In the partial agonist clenbuterol-bound and partial agonist tulobuterol-bound states, β 2 AR exists in equilibrium between the PIFon and PIFoff 2 conformations, exhibiting significant signaling with reduced efficacies. In the tulobuterol-bound state, where the efficacy is lower than that of the clenbuterol-bound state, the population of the PIFon conformation is smaller. In the neutral antagonist alprenolol-bound state, β 2 AR primarily adopts the PIFoff 1 and PIFoff 2 conformations, in equilibrium with a small population of the PIFon conformation. The presence of the small population of the PIFon conformation accounts for the basal activity of β 2 AR. In the inverse agonist carazolol-bound state, β 2 AR exists in equilibrium between the PIFoff 1 and PIFoff 2 conformations, exhibiting the inhibition of the basal activities. g Plots of the reported maximum cAMP responses against the population of PIFon in each ligand-bound state, calculated from the M82 signals P/I/F motif conformation in the crystal structure of a ternary complex with a full agonist and a G protein. , a signal regulation mechanism was proposed (Fig. 1f) . (i) In the full agonist-bound state, most of the β 2 AR molecules assume the active conformation. (ii) In the partial agonist-bound states, β 2 AR exists in equilibrium between the inactive and active conformations, and the populations of the two conformations determine the efficacies. (iii) In the neutral antagonist alprenolol-bound state, β 2 AR exists in equilibrium between two major inactive conformations and one minor active conformation. The weak basal activity is due to the existence of the minor PIFon conformation. (iv) In the inverse agonist-bound state, β 2 AR exists in equilibrium between the two locally different inactive conformations. The PIFon populations, calculated from the M82 signals, were correlated with the maximum cAMP levels of cells expressing β 2 AR in the presence of the ligands (Fig. 1g) , and thus the observed conformational dynamics is related to the ligand efficacy.
Conformational equilibria related to variations in ligand efficacy have been observed in other regions of β 2 AR. With CF 3 probes at C265
6.27 and C327 7.54 near the cytoplasmic tips of TMVI and TMVII, respectively, equilibria between the inactive and active-like conformations were observed, and the population of the active-like state correlated with the ligand efficacy (Liu et al. 2012) . Remarkably, the exchange rates seen for the CF 3 probe at C265
6.27 were smaller than those observed for the P/I/F motif; i.e., slower than 10 s −1 , suggesting that the exchange rates of the P/I/F motif activation are different from those of the conformational exchange near the intracellular surface . CPMG experiments with another CF 3 probe, 2-bromo-4-trifluoromethylacetanilide, at C265 6.27 of β 2 AR in the apo and inverse agonist-bound states indicated that C265
6.27 underwent conformational exchange at a rate > 1,000 s −1 , suggesting that in the inactive state, the cytoplasmic surface region of β 2 AR is characterized as a manifold of rapidly exchanging substates Staus et al. 2016 ).
Biased signaling-related conformational dynamics of μ-opioid receptor In addition to the activation of signal transduction mediated by G proteins, GPCRs stimulate G protein-independent signal transduction mediated by arrestin. Various GPCR ligands can modulate signaling through the G protein and arrestin pathways via different mechanisms: GPCR ligands that stimulate both of the signaling pathways and those that preferentially modulate one of the signaling pathways are referred to as Bbalanced ligands^and Bbiased ligands,^respectively (Urban et al. 2007 ).
In the case of the μ-opioid receptor (μOR), a GPCR stimulated by various opioid drugs, such as morphine, signaling through the G protein plays a key role in the desired analgesic properties of morphine, whereas signaling through β-arrestin is associated with adverse effects, such as respiratory depression (Bohn et al. 1999) . μOR stimulation by oliceridine elicits signaling through Gi, the inhibitory G protein for adenylyl cyclase, but markedly reduces signaling through β-arrestin (Chen et al. 2013) (Fig. 2a) . In addition, the N152A mutant of the μ-opioid receptor constitutively activates β-arrestin- , and the equilibrium within the active substates is shifted toward the conformation preferred for G protein activation. In the DAMGO-bound state of the MOR N152 3.35 A mutant, where MOR adopts only the active conformation, the equilibrium among the active substates is shifted toward the conformation preferred for arrestin activation. e Correlation between the normalized chemical shifts of the M245 5.49 NMR signals and the value of the bias factor, which is the ratio of the β-arrestin signaling efficacy to the G protein signaling efficacy. f Structure-function relationships of derivatives of the MOR ligand, oliceridine. Modification of either of the two aromatic rings that are highlighted in boxes results in the selective modulation of β-arrestin signaling mediated signaling (Fenalti et al. 2014; Okude et al. 2015) . G protein-biased ligands of μOR, including oliceridine, reportedly increase the analgesia effects and reduce the on-target adverse effects in comparison with morphine (Chen et al. 2013; Majumdar and Devi 2018) . The potential therapeutic applications of the biased signaling of various GPCRs have been proposed (Smith et al. 2018) . Therefore, the mechanisms underlying the biased signaling of μOR are important for understanding the functions of GPCRs and for drug development.
Crystal structures of μOR have been solved in the antagonist-bound form and the ternary complex form composed of μOR, the full agonist, and the G protein-mimicking nanobody (Huang et al. 2015; Manglik et al. 2012) . In addition, the cryo-electron microscopy structure of the ternary complex with a full agonist and a G protein has recently been reported (Koehl et al. 2018) . Activation-induced conformational changes of the P/I/F motif and the cytoplasmic cavity formation were also observed for the μOR structures. These structures were complemented in important ways by the following NMR studies (Okude et al. 2015) . M245 5.49 is close to the P/I/F motif and undergoes a conformational change upon activation in human μOR (Fig. 2b) . The chemical shifts of M245 5.49 in the balanced full agonist-bound state were between those of the G protein-biased partial agonist-bound state and those of the β-arrestin-biased mutant bound to the full agonist (Fig. 2c) . These results, along with the temperaturedependent shift of these resonances, suggest that μOR adopts multiple active conformations, including the conformations that preferably activate either G proteinmediated signaling or β-arrestin-mediated signaling, that these conformations exchange faster than the chemical shift difference (> 100 s −1 ), and that the equilibrium is skewed toward the former and latter conformations in the G protein-biased ligand-bound state and the full agonistbound state of the β-arrestin-biased mutant, respectively (Fig. 2d) . The chemical shifts of M245 5.49 correlate well with the bias factors in each state (Fig. 2e) , suggesting that the conformational dynamics of μOR, observed by NMR, are related to the bias factor. , and M283 6.36 exist on the intracellular sides of TMIII, TMV, and TMVI (Fig. 2b) , and their chemical shifts should be sensitive to the conformational changes of TMVII, as well as TMIII, TMV, and TMVI. The chemical shifts of M163 3.46 , M257 5.61 , and M283
6.36 also correlate with the bias factor (Fig. 2c) , suggesting that the bias factordependent conformational equilibrium observed for M245 5.49 accompanies the coupled conformational changes on the intracellular sides of TMIII, TMV, TMVI, and TMVII.
A comparison of oliceridine derivatives, composed of the 2-[6-oxaspiro[4.5]decan-9-yl] ethylamine scaffold and aromatic groups attached to the oxaspiro[4,5]decan and ethanolamine moieties (Fig. 2f) , including compounds 6 to 11 and 13 to 19, revealed that the modification of either of the two aromatic rings results in the selective modulation of β-arrestin signaling (Chen et al. 2013 ). These structure-activity relationships of the oliceridine derivatives are in agreement with the population shifts of the conformational equilibria that accompany the global conformational changes in TMIII, TMV, TMVI, and TMVII, as revealed by NMR. These relationships between the chemical structures of GPCR ligands and their biased signaling would be helpful for the design of biased ligands.
Function-related dynamics of GPCRs in the lipid bilayer environment
Whereas the β 2 AR used in the previous NMR studies was solubilized by detergents, which are widely utilized for structural investigations of membrane proteins, β 2 AR is embedded in the lipid bilayer. Reconstituted high-density lipoproteins (rHDLs), also referred to as nanodiscs, can accommodate membrane proteins within a 10-nm-diameter disc-shaped lipid bilayer stabilized by α-helical amphipathic membrane scaffold proteins (MSPs) (Fig. 3a) (Bayburt et al. 2002) . The rHDLs reportedly provide a lipid environment with more native-like properties, as compared with liposomes, in terms of the lateral pressure and curvature profiles, since detergent Although the molecular masses of GPCRs in rHDLs can exceed 200 kDa, the sensitivity enhancement by deuteration enabled the observation of the alanine and methionine methyl groups of β 2 AR in rHDLs Kofuku et al. 2018 ). In the methyl-TROSY spectra of β 2 AR in the weak partial agonist-bound or partial agonist-bound states in rHDLs, M82
2.53 exhibited resonances with broad and complex lineshapes, suggesting that the exchange rates between the M82 D , M82 U , and M82 A conformations of β 2 AR in rHDLs are lower than those for β 2 AR in DDM micelles (Fig. 3b, c) . Furthermore, these resonances shifted toward M82 A , in comparison with those of β 2 AR in DDM micelles, suggesting that the population of the M82 A conformation of β 2 AR in rHDLs is higher than that in DDM micelles (Fig.  3b, c) . Based on simulations of the M82
2.53 resonances in each ligand-bound state of β 2 AR, we concluded that the exchange rates between the active and inactive conformations were lower in rHDLs than those in DDM micelles and that the population of the active conformation was higher in rHDLs than that in DDM micelles (Fig. 3d) .
A time course simulation of G protein signaling, based on the exchange rates of β 2 AR when bound to a neutral antagonist or a weak partial agonist and the previously reported intracellular signaling reaction rates (Saucerman et al. 2003) , revealed that the G protein activation and the increase in cAMP occurred on timescales of hundreds of milliseconds and seconds, respectively (Fig. 3e) . This is in agreement with the experimentally observed cAMP increases within seconds (Nikolaev et al. 2004 ) and the G protein-coupled inward rectifier channel activations within hundreds of milliseconds (Bünemann et al. 2001 ). In the case of receptor tyrosine kinases (RTKs), which also mediate extracellular ligand-dependent cellular responses through multiple intracellular effectors, dimerization and subsequent tyrosine phosphorylation occur on the timescale of seconds to minutes, and thus the signaling from RTKs is slower than that of GPCRs (Swift et al. 2011) . The fast conformational change of GPCRs is a result of the preformation of the active conformation, as exemplified by their basal activity, to enable rapid neurotransmission and sensory perception.
The maximum cAMP responses, calculated using the populations of the PIFon conformations of β 2 AR in rHDLs, correlated better with the experimental values than those calculated for β 2 AR in DDM micelles (Fig. 3f) . NMR analyses of other membrane proteins embedded in rHDLs also revealed that the conformational equilibria and the functions of membrane proteins are affected by the lipid bilayer environments (Imai et al. 2012; Minato et al. 2016) . Therefore, NMR investigations of GPCRs, as well as other membrane proteins, in the lipid bilayer environments of rHDLs are necessary for accurate measurements of the exchange rates and populations in conformational equilibrium.
Conclusions and future perspectives
As described above, NMR studies have demonstrated that GPCRs exist in function-related conformational equilibria, and the populations of the substates are related to the signaling activities. The information about the function-related conformational equilibria opens an avenue for the rational design of agonists with predictable efficacies and biased signaling. Further NMR analyses for obtaining precise information about the conformation of each substate in the equilibria would provide an answer to the questions of how the GPCR ligands drive the equilibria and how the substates in the equilibria exhibit different signaling activities.
Under physiological conditions, GPCRs are embedded in the lipid bilayers of tissues with various lipid compositions, and the signaling activities of GPCRs can be affected by the lipid compositions of the bilayers. Reconstitution of GPCRs into rHDL lipid bilayers thus will allow for the examination of the effects of various compositions of lipid bilayers on the activities and conformational equilibria of GPCRs by solution NMR experiments.
